Live Breaking News & Updates on Actify Neurotherapies

Stay updated with breaking news from Actify neurotherapies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Psychedelic Wellness-Focused Company DELIC Holdings Announces Appointment of Kyle Snook to Board of Advisors


DELIC or the
Company ) (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness-focused company, is pleased to announce the appointment of Kyle Snook, former COO of Actify Neurotherapies, to the Board of Advisors of the Company. 
Matt Stang commented On behalf of the team at DELIC, I am very excited to welcome Kyle to the Board of Advisors. His multi-faceted background will be an invaluable asset to the team. I look forward to working together and building DELIC to becoming a leader in the sector.
Kyle Snook was the COO of Actify Neurotherapies, a Venture backed multi-site startup formerly the largest provider of IV Ketamine Therapy nationwide. As COO Kyle was responsible for all business operations including multi-site operations and growth, marketing and financial management. Kyle received his undergraduate degree from West Point and served as an Infantry officer in the United States Army, including a combat tour to Afghanistan. Kyle also received his MBA from Harvar ....

New York , United States , West Point , British Columbia , Actify Neurotherapies , Matt Stang , United States Army , Holdings Inc , Company Board Of Directors , Delic Holdings Inc , Ketamine Infusion Center , Harvard Business School , Company Incentive Stock , Board Of Advisors The Company , Canadian Securities Exchange , Kyle Snook , Harvard Business , New York City Metro , Incentive Stock Option , Complex Biotech Discovery Ventures , Securities Act , Looking Information , United States Private Securities , Litigation Reform Act , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் ,

Growing Medical Support Helps Buoy Psychedelic Research


Growing Medical Support Helps Buoy Psychedelic Research
FinancialBuzz.com News Commentary
Share this article
Share this article
NEW YORK, Dec. 14, 2020 /PRNewswire/ There is a plethora of innovations that scientists and researchers have accomplished in biotechnology in recent years. Among the popular fields of study for biotech companies are gene editing, tissue engineering and regeneration, nanobiotechnology and others. In addition, new segments under the biotech umbrella are constantly being developed. For example, the medical cannabis segment has rapidly emerged in recent years, and the continuously growing acceptance of psychedelic drugs is further evidence. According to recent 
studies by a number of universities and research institutions, data indicates the usefulness of potential applications of psilocybin. It is a naturally occurring substance that is being examined for the potential use in the treatment of psychiatric conditions. Currently, psychede ....

United States , Actify Neurotherapies , Michael Frank , Steve Levine , Michael Tan , Seth Lederman , Companya Subordinate Voting Share , Tonix Pharmaceuticals , Medicine Inc , Tonix Pharmaceuticals Holding Corp , Reed Research Group , Mindmed Co , Psychiatry Consortium , Company The Units , Numinus Wellness Inc , Canaccord Genuity Corp , Company Interviews , Therapeutics Ltd , Drug Administration , Exchange Inc , University Of Wisconsin , Health Canada , Medicine Mindmed Inc , Tonix Pharmaceuticals Holding , Numinus Wellness , Revive Therapeutics ,